Literature DB >> 33331663

Respiratory muscle training for cystic fibrosis.

Gemma Stanford1,2, Harrigan Ryan3, Arturo Solis-Moya4.   

Abstract

BACKGROUND: Cystic fibrosis is the most common autosomal recessive disease in white populations, and causes respiratory dysfunction in the majority of individuals. Numerous types of respiratory muscle training to improve respiratory function and health-related quality of life in people with cystic fibrosis have been reported in the literature. Hence a systematic review of the literature is needed to establish the effectiveness of respiratory muscle training (either inspiratory or expiratory muscle training) on clinical outcomes in cystic fibrosis. This is an update of a previously published review.
OBJECTIVES: To determine the effectiveness of respiratory muscle training on clinical outcomes in people with cystic fibrosis. SEARCH
METHODS: We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials register comprising of references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings. Date of most recent search: 11 June 2020. A hand search of the Journal of Cystic Fibrosis and Pediatric Pulmonology was performed, along with an electronic search of online trial databases. Date of most recent search: 05 October 2020. SELECTION CRITERIA: Randomised controlled studies comparing respiratory muscle training with a control group in people with cystic fibrosis. DATA COLLECTION AND ANALYSIS: Review authors independently selected articles for inclusion, evaluated the methodological quality of the studies, and extracted data. Additional information was sought from trial authors where necessary. The quality of the evidence was assessed using the GRADE system. MAIN
RESULTS: Authors identified 20 studies, of which 10 studies with 238 participants met the review's inclusion criteria. There was wide variation in the methodological and written quality of the included studies. Four of the 10 included studies were published as abstracts only and lacked concise details, thus limiting the information available. Eight studies were parallel studies and two of a cross-over design. Respiratory muscle training interventions varied dramatically, with frequency, intensity and duration ranging from thrice weekly to twice daily, 20% to 80% of maximal effort, and 10 to 30 minutes, respectively. Participant numbers ranged from 11 to 39 participants in the included studies; five studies were in adults only, one in children only and four in a combination of children and adults. No differences between treatment and control were reported in the primary outcome of pulmonary function (forced expiratory volume in one second and forced vital capacity) or postural stability (very low-quality evidence). Although no change was reported in exercise capacity as assessed by the maximum rate of oxygen use and distance completed in a six minute walk test, a 10% improvement in exercise duration was found when working at 60% of maximal effort in one study (n = 20) (very low-quality evidence). In a further study (n = 18), when working at 80% of maximal effort, health-related quality of life improved in the mastery and emotion domains (very low-quality evidence). With regards to the review's secondary outcomes, one study (n = 11) found a change in intramural pressure, functional residual capacity and maximal inspiratory pressure following training (very low-quality evidence). Another study (n=36) reported improvements in maximal inspiratory pressure following training (P < 0.001) (very low-quality evidence). A further study (n = 22) reported that respiratory muscle endurance was longer in the training group (P < 0.01). No studies reported significant differences on any other secondary outcomes. Meta-analyses could not be performed due to a lack of consistency and insufficient detail in reported outcome measures. AUTHORS'
CONCLUSIONS: There is insufficient evidence to suggest whether this intervention is beneficial or not. Healthcare practitioners should consider the use of respiratory muscle training on a case-by-case basis. Further research of reputable methodological quality is needed to determine the effectiveness of respiratory muscle training in people with cystic fibrosis. Researchers should consider the following clinical outcomes in future studies; respiratory muscle function, pulmonary function, exercise capacity, hospital admissions, and health-related quality of life. Sensory-perceptual changes, such as respiratory effort sensation (e.g. rating of perceived breathlessness) and peripheral effort sensation (e.g. rating of perceived exertion) may also help to elucidate mechanisms underpinning the effectiveness of respiratory muscle training.
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2020        PMID: 33331663      PMCID: PMC8406523          DOI: 10.1002/14651858.CD006112.pub5

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  39 in total

Review 1.  Exercise is medicine in cystic fibrosis.

Authors:  Courtney M Wheatley; Brad W Wilkins; Eric M Snyder
Journal:  Exerc Sport Sci Rev       Date:  2011-07       Impact factor: 6.230

2.  The effects of inspiratory muscle training in patients with cystic fibrosis.

Authors:  M I Asher; R L Pardy; A L Coates; E Thomas; P T Macklem
Journal:  Am Rev Respir Dis       Date:  1982-11

3.  Ventilatory muscle endurance training in normal subjects and patients with cystic fibrosis.

Authors:  T G Keens; I R Krastins; E M Wannamaker; H Levison; D N Crozier; A C Bryan
Journal:  Am Rev Respir Dis       Date:  1977-11

Review 4.  Inspiratory muscle training for cystic fibrosis.

Authors:  Brian W Houston; Nicola Mills; Arturo Solis-Moya
Journal:  Cochrane Database Syst Rev       Date:  2013-11-21

5.  Tube breathing as a new potential method to perform respiratory muscle training: safety in healthy volunteers.

Authors:  Ralph J H Koppers; Petra J E Vos; Hans Th M Folgering
Journal:  Respir Med       Date:  2005-08-29       Impact factor: 3.415

6.  A short-term comparison of two methods of sputum expectoration in cystic fibrosis.

Authors:  K Chatham; A A Ionescu; L S Nixon; D J Shale
Journal:  Eur Respir J       Date:  2004-03       Impact factor: 16.671

Review 7.  Cystic fibrosis.

Authors:  Felix Ratjen; Scott C Bell; Steven M Rowe; Christopher H Goss; Alexandra L Quittner; Andrew Bush
Journal:  Nat Rev Dis Primers       Date:  2015-05-14       Impact factor: 52.329

8.  Respiratory training with a specific device in cystic fibrosis: a prospective study.

Authors:  R Sartori; E Barbi; F Poli; L Ronfani; F Marchetti; A Amaddeo; A Ventura
Journal:  J Cyst Fibros       Date:  2008-02-01       Impact factor: 5.482

Review 9.  Respiratory muscle training for patients with chronic obstructive pulmonary disease.

Authors:  W D Reid; B Samrai
Journal:  Phys Ther       Date:  1995-11

Review 10.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

View more
  2 in total

Review 1.  Exercise versus airway clearance techniques for people with cystic fibrosis.

Authors:  Katie D Heinz; Adam Walsh; Kevin W Southern; Zoe Johnstone; Kate H Regan
Journal:  Cochrane Database Syst Rev       Date:  2022-06-22

2.  Respiratory Muscle Strength: New Technology for Easy Assessment.

Authors:  Vasileios T Stavrou; Konstantinos N Tourlakopoulos; Zoe Daniil; Konstantinos I Gourgoulianis
Journal:  Cureus       Date:  2021-05-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.